Dr. Jose A. Figueroa

Oncology
Lubbock Urology Associates
4515 Marsha Sharp Fwy, 
Lubbock, TX 
Lubbock Urology Associates
4515 Marsha Sharp Fwy, 
Lubbock, TX 

Overview

Jose Figueroa is an Oncologist practicing medicine in Lubbock, Texas.

His clinical expertise encompasses Inflammatory Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Breast Cancer, and EGFR Positive Lung Cancer.

He is actively involved in clinical research, co-authoring 25 peer reviewed articles and participating in 4 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in NM

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

Lubbock Urology Associates
4515 Marsha Sharp Fwy, Lubbock, TX 79407
Other Locations
Microbiology at Cancer Center
2717 Michaelangelo Dr, Edinburg, TX 78539

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Imiquimod, in Patients With Progressive and/or Refractory Solid Malignancies
Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Imiquimod, in Patients With Progressive and/or Refractory Solid Malignancies
Enrollment Status: Terminated
Publish Date: April 24, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 1/Phase 2
Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Low Dose GM-CSF, As Consolidation Treatment in Patients With Hematologic Malignancies
Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Low Dose GM-CSF, As Consolidation Treatment in Patients With Hematologic Malignancies
Enrollment Status: Withdrawn
Publish Date: October 14, 2019
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen (TAPA)-Pulsed Dendritic Cell (DC) Therapy and Low Dose GM-CSF, as Consolidation Therapy in Patients With Metastatic Solid Malignancies
Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen (TAPA)-Pulsed Dendritic Cell (DC) Therapy and Low Dose GM-CSF, as Consolidation Therapy in Patients With Metastatic Solid Malignancies
Enrollment Status: Withdrawn
Publish Date: August 28, 2018
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Low Dose GM-CSF, in Patients With Progressive and/or Refractory Hematologic Malignancies
Phase I/II Study of Low-Dose Cyclophosphamide, Tumor Associated Peptide Antigen-Pulsed Dendritic Cell Therapy and Low Dose GM-CSF, in Patients With Progressive and/or Refractory Hematologic Malignancies
Enrollment Status: Withdrawn
Publish Date: August 28, 2018
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

25 Total Publications

Galectin 3 expression in gastrointestinal tumors identified through comprehensive bioinformatic mapping.
Galectin 3 expression in gastrointestinal tumors identified through comprehensive bioinformatic mapping.
Journal: Discover oncology
Published: September 11, 2025
Similar Doctors
Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

UMC Cancer Center

602 Indiana Ave, 
Lubbock, TX 
 (1.7 miles away)
806-775-8600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Hutson is an Oncologist practicing medicine in Lubbock, Texas. Dr. Hutson is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Hutson is currently accepting new patients.

Expertise in
54
conditions
Expertise in
54
conditions
Referral may be required
Before you request
4101 22nd Place, 
Lubbock, TX 
 (0.4 miles away)
806-725-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ibrahim Shalaby is an Oncologist practicing medicine in Lubbock, Texas. Dr. Shalaby is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Pleuropulmonary Blastoma. Dr. Shalaby is currently accepting new patients.

Expertise in
54
conditions
Expertise in
54
conditions
Referral may be required
Before you request
4101 22nd Place, 
Lubbock, TX 
 (0.4 miles away)
806-725-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Close is an Oncologist practicing medicine in Lubbock, Texas. Dr. Close is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, and Familial Colorectal Cancer. Dr. Close is currently accepting new patients.

Frequently Asked Questions about Dr. Jose A. Figueroa

How do I make an appointment with Dr. Jose A. Figueroa?

You can book an appointment with Dr. Jose A. Figueroa by calling their office at 806-744-7223. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jose A. Figueroa a top-rated expert for Inflammatory Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jose A. Figueroa is classified as an Experienced expert for Inflammatory Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jose A. Figueroa specialize in?

While Dr. Jose A. Figueroa is a Oncology, they have specific expertise in Inflammatory Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Jose A. Figueroa participate in research or clinical trials?

Yes. Dr. Jose A. Figueroa has published 25 articles and abstracts on conditions like Inflammatory Breast Cancer. You can view a list of Dr. Jose A. Figueroa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jose A. Figueroa accept my insurance?

Dr. Jose A. Figueroa accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 806-744-7223 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Figueroa's expertise for a condition
ConditionClose
        View All 25 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile